Deep Dive into Esophageal Cancer Genome
A team of UK researchers dug deep into the genomic roots of more than 550 cases of Esophageal Adenocarcinoma (EAC), [...]
Make Millions Available for Esophageal Cancer Research
ECAN's Medical Research Campaign What our Campaign Will Do: The United States Congress appropriated $90 million dollars this year for a [...]
First Patient Dosed in Phase 3 Trial Testing Tyvyt as First-line Therapy for Esophageal Cancer
First Esophageal Cancer patient is dosed in Phase 3 clinical trial using immune checkpoint inhibitor Tyvyt (sintilimab injection), in [...]
$26 Million ‘Grand Challenge’ Project Will Probe Role of Inflammation in Cancer
Unprecedented International Collaboration will Focus on Esophageal and other Cancers with $26 Million UK Grant. Read more about this [...]
Newly Diagnosed Cancer Patients who have Hepatitis are Unaware of the Hepatitis Status
Study Finds Many Newly Diagnosed Cancer Patients who have Hepatitis are Unaware of the Hepatitis Status - Prompting a [...]
A Survivor’s Story
Gary Gilbert of York, Pennsylvania was 72 when he was diagnosed with Stage III Esophageal Adenocarcinoma. This is his story.
The Power of Purpose and Sharing
As both a caregiver and a patient, I’ve had lots of on-the-job training. It started with my mother’s colon cancer [...]
It’s Hard – But it’s Survivable
I’ve always had a complicated relationship with food. It started when I was around five years old. Until then, I [...]
Deep Cuts to Cancer Research
Budget Plan Risks Hard-Fought Research Gains President Trump’s budget proposal for FY 2018 calls for a drastic 20% cut to [...]
Esophageal Cancer Genome
ECAN’s President and CEO Mindy Mintz Mordecai recently had the opportunity to interview Dr. Adam Bass, co-chair of the [...]